Nang Kuang and Zentrale Enter into an Exclusive Agreement to Commercialize Biological Product in Chinese MainlandNang Kuang and Zentrale Enter into an Exclusive Agreement
Nang Kuang and Pharma-Zentrale GmbH (Zentrale) have signed an exclusive agreement for the commercialization of an orally administered biological product in Mainland China for the treatment of diarrhea in infants, children and adults.
Zentrale is a German century-old company specialized in probiotic- and phyto-pharmaceuticals, biological APIs as well as contract manufacturing.